Table 1. Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Point-of-care Testing (POCT) for Cardiovascular Diseases Market Restraints

Table 3. Point-of-care Testing (POCT) for Cardiovascular Diseases Market Trends

Table 4. Point-of-care Testing (POCT) for Cardiovascular Diseases Industry Policy

Table 5. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Share by Company, 2019-2024, Ranked by Data of 2024

Table 7. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Company, 2019-2024, Ranked by Data of 2024

Table 9. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)

Table 10. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Mergers & Acquisitions, Expansion Plans

Table 12. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Manufacturers Product Type

Table 13. Head Office and Point-of-care Testing (POCT) for Cardiovascular Diseases Production Site of Key Manufacturer

Table 14. Point-of-care Testing (POCT) for Cardiovascular Diseases Capacity of Major Manufacturers and Future Plan

Table 15. China Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024

Table 16. China Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024

Table 17. China Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity by Company, 2019-2024, Ranked by Data of 2024

Table 18. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 19. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Production by Region, 2019-2024, (K Units)

Table 20. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Production Forecast by Region, 2024-2030, (K Units)

Table 21. Global Key Players of Point-of-care Testing (POCT) for Cardiovascular Diseases Upstream (Raw Materials)

Table 22. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Typical Customers

Table 23. Point-of-care Testing (POCT) for Cardiovascular Diseases Typical Distributors

Table 24. By Type, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 25. By Application, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 26. By Region, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 27. By Region, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value, 2019-2030, US$ Million

Table 28. By Region, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Table 29. By Country, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Country, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value, 2019-2030, US$ Million

Table 31. By Country, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share, 2019-2030

Table 32. By Country, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Table 33. By Country, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2019-2030

Table 34. Roche Company Information, Head Office, Market Area, and Industry Position

Table 35. Roche Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 36. Roche Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 37. Roche Company Profile and Main Business

Table 38. Roche Recent Developments

Table 39. Abbott Company Information, Head Office, Market Area, and Industry Position

Table 40. Abbott Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 41. Abbott Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Abbott Company Profile and Main Business

Table 43. Abbott Recent Developments

Table 44. BioMerieux Company Information, Head Office, Market Area, and Industry Position

Table 45. BioMerieux Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 46. BioMerieux Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. BioMerieux Company Profile and Main Business

Table 48. BioMerieux Recent Developments

Table 49. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information, Head Office, Market Area, and Industry Position

Table 50. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 51. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Profile and Main Business

Table 53. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments

Table 54. Guangzhou Wondfo Biotech Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 55. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 56. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Guangzhou Wondfo Biotech Co.,Ltd. Company Profile and Main Business

Table 58. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments

Table 59. Getein Biotech, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 60. Getein Biotech, Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 61. Getein Biotech, Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Getein Biotech, Inc. Company Profile and Main Business

Table 63. Getein Biotech, Inc. Recent Developments

Table 64. Sinocare Inc Company Information, Head Office, Market Area, and Industry Position

Table 65. Sinocare Inc Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 66. Sinocare Inc Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Sinocare Inc Company Profile and Main Business

Table 68. Sinocare Inc Recent Developments

Table 69. Relia Bioengineering Co., Ltd Company Information, Head Office, Market Area, and Industry Position

Table 70. Relia Bioengineering Co., Ltd Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 71. Relia Bioengineering Co., Ltd Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Relia Bioengineering Co., Ltd Company Profile and Main Business

Table 73. Relia Bioengineering Co., Ltd Recent Developments

Table 74. Beijing Hotgen Biotech Co.,ltd. Company Information, Head Office, Market Area, and Industry Position

Table 75. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 76. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Beijing Hotgen Biotech Co.,ltd. Company Profile and Main Business

Table 78. Beijing Hotgen Biotech Co.,ltd. Recent Developments

Table 79. Assure Tech (Hangzhou) Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 80. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 81. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Assure Tech (Hangzhou) Co.,Ltd. Company Profile and Main Business

Table 83. Assure Tech (Hangzhou) Co.,Ltd. Recent Developments

Table 84. Nanjing Vazyme Biotech Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 85. Nanjing Vazyme Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 86. Nanjing Vazyme Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Nanjing Vazyme Biotech Co.,Ltd. Company Profile and Main Business

Table 88. Nanjing Vazyme Biotech Co.,Ltd. Recent Developments

Table 89. Siemens Healthineers Company Information, Head Office, Market Area, and Industry Position

Table 90. Siemens Healthineers Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 91. Siemens Healthineers Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Siemens Healthineers Company Profile and Main Business

Table 93. Siemens Healthineers Recent Developments

Table 94. Danaher Company Information, Head Office, Market Area, and Industry Position

Table 95. Danaher Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 96. Danaher Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Danaher Company Profile and Main Business

Table 98. Danaher Recent Developments

Table 99. Sansure Biotech Inc. Company Information, Head Office, Market Area, and Industry Position

Table 100. Sansure Biotech Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Models, Specifications, and Application

Table 101. Sansure Biotech Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Sansure Biotech Inc. Company Profile and Main Business

Table 103. Sansure Biotech Inc. Recent Developments

List of Figures

Figure 1. Point-of-care Testing (POCT) for Cardiovascular Diseases Picture

Figure 2. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value, (US$ million) & (2019-2030)

Figure 3. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, (K Units) & (2019-2030)

Figure 4. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Selling Price (ASP), (2019-2030) & (US$/Unit)

Figure 5. China Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value, (US$ million) & (2019-2030)

Figure 6. China Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity (K Units) & (2019-2030)

Figure 7. China Point-of-care Testing (POCT) for Cardiovascular Diseases Average Selling Price (ASP), (US$/Unit) & (2019-2030)

Figure 8. By Consumption Value, China Point-of-care Testing (POCT) for Cardiovascular Diseases Market Share of Global, 2019-2030

Figure 9. By Sales Quantity, China Point-of-care Testing (POCT) for Cardiovascular Diseases Market Share of Global, 2019-2030

Figure 10. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Point-of-care Testing (POCT) for Cardiovascular Diseases Key Participants, Market Share, 2024

Figure 12. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Capacity, Production and Capacity Utilization, 2019-2030

Figure 13. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Capacity Market Share by Region, 2024 VS 2030

Figure 14. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Production Market Share & Forecast by Region, 2019-2030

Figure 15. Point-of-care Testing (POCT) for Cardiovascular Diseases Industry Chain

Figure 16. Point-of-care Testing (POCT) for Cardiovascular Diseases Procurement Model

Figure 17. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Model

Figure 18. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Channels, Direct Sales, and Distribution

Figure 19. Based on Immunochromatography

Figure 20. Based on Chemiluminescence Technology

Figure 21. Based on Biosensor

Figure 22. Based on Colloidal Gold

Figure 23. Others

Figure 24. By Type, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value, 2019-2030, US$ Million

Figure 25. By Type, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share, 2019-2030

Figure 26. By Type, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Figure 27. By Type, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2019-2030

Figure 28. By Type, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 29. Hospital

Figure 30. lndependent Testing Organization

Figure 31. By Application, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value, 2019-2030, US$ Million

Figure 32. By Application, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share, 2019-2030

Figure 33. By Application, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Figure 34. By Application, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2019-2030

Figure 35. By Application, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 36. By Region, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share, 2019-2030

Figure 37. By Region, Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2019-2030

Figure 38. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 39. By Country, North America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share, 2024

Figure 40. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share, 2024

Figure 42. Asia Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 43. By Country/Region, Asia Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share, 2024

Figure 44. South America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 45. By Country, South America Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value Market Share, 2024

Figure 46. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 47. U.S. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Figure 48. By Type, U.S. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 49. By Application, U.S. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 50. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Figure 51. By Type, Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 52. By Application, Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 53. China Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Figure 54. By Type, China Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 55. By Application, China Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 56. Japan Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Figure 57. By Type, Japan Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 58. By Application, Japan Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 59. South Korea Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Figure 60. By Type, South Korea Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 61. By Application, South Korea Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 62. Southeast Asia Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Figure 63. By Type, Southeast Asia Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 64. By Application, Southeast Asia Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 65. India Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Figure 66. By Type, India Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 67. By Application, India Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity, 2019-2030, (K Units)

Figure 69. By Type, Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 70. By Application, Middle East & Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Quantity Market Share, 2024 VS 2030

Figure 71. Research Methodology

Figure 72. Breakdown of Primary Interviews

Figure 73. Bottom-up and Top-down Approaches

Figure 74. Top-down Approaches